Advanced Micro Devices

Eli Lilly

Altria Group

Tuesday's Notable Option Activity: AMD, MO, LLY

礼来

Eli Lilly's 15min chart triggers Bollinger Bands Narrowing, KDJ Death Cross indication.

Should You Buy Eli Lilly Amid the Healthcare Sector's Slide? Consider This ETF Option

Should You Buy Eli Lilly Amid Its 15.6% Decline? Consider a Low-Cost Vanguard ETF

Vanguard Health Care ETF

Eli Lilly Stock: Buy the Dip with a Low-Cost Vanguard ETF

Risk<ul> <li>Technical indicators show that the market is in a weak state and bearish signals are clearly dominant with three negative signals recorded recently.</li> <li>Analyst ratings for LLY are inconsistent with one Sell and one Buy recommendation currently active.</li> <li>Fund flow analysis indicates a negative overall trend with large and extra-large order inflows being negative.</li></ul>

Key Factors

Eli Lilly's trading volume plummeted 41.29% to $2.57 billion on March 23, 2026, despite a 0.42% rise in share price to $913.46.Eli Lilly is awaiting an April 10, 2026, FDA decision on its oral weight loss drug orforglipron, a key catalyst for future growth and valuation validation.Eli Lilly pledged $3 billion for orforglipron manufacturing in China, aiming for a first-mover advantage in the oral GLP-1 market and pending NMPA regulatory approval.Eli Lilly reduced the price of its weight-loss vials by $50-$100 to remain competitive in the cutthroat US obesity drug market.Eli Lilly's stock has declined 13% year-to-date, reflecting investor concerns over regulatory delays and valuation pressures ahead of key FDA decisions.

Recent Updates

LLY News